- Brands
- Offerings
- Diagnostic Panels
- Knowledge Center
- Diagnostics
Core Laboratory
Core Laboratory
SARS-CoV-2 Clinician Tools
On average, COVID-19 cases may be 10x higher than what is currently being recordEd1
We must identify new, recent and past infections to understand true spread and contain outbreaks.
Serology testing can help.
Resources & Tools
Serology testing infographic
A printable document that explains the value of serology tests and the need to more accurately identify infections.
Interactive COVID-19 test tool
Understand how COVID-19 tests can be used to understand a patient's status throughout the course of infection and recovery.
Clinical Assessment White Paper
A consolidation of literature that discusses the value of combining serology with RNA and Antigen tests in a clinical environment.
covid-19 clinician webinars
Webinars and conversations with clinicians about managing patient care during the pandemic.
There are Challenges Diagnosing Both Acute Symptomatic and Asymptomatic COVID-19 Infections―And This Will Only Grow More Challenging During Flu and Cold Season
We need to identify all infected patients to better understand impacts on patient wellness moving forward
What can be done?
Serology tests can...
Allow identification of recent infection and evaluation of disease course
Differentiate current, recent and previous infections
Identify recent or prior infection for patients with no known exposure or symptoms
Serology Testing is Essential to manage the pandemic and Patient care
Serology testing is important for health management of individual patients and the community at large.
Resources to help you manage Patient Care
Abbott is committed to support communities worldwide with resources and technologies to fight the evolving threat of COVID-19. As you work to continue to respond to the pandemic and provide patient care, we hope you find these resources helpful.
Clinical Assessment of COVID-19
A consolidation of literature that discusses the value of combining serology with RNA and Antigen COVID-19 tests in a clinical environment.
The paper also shares common patient presentation scenarios that clinicians are being faced with and ideas of what types of testing they may consider to help stem the spread of COVID-19 and manage patient care.
Clinician Webinars
-
: 19:12
: 2020-10-16
Megan Berman, MD FACP, discusses interactions with patients during COVID-19 and questions regarding testing with Michael Laposata, MD, PhD.
Explore
Our extensive assay menu helps physicians make timely, informed decisions throughout the continuum of care.
Explore our automated lab-based tests that detects the human-antibody response to the novel coronavirus.
Explore how we're addressing the COVID-19 pandemic and the available products for your laboratory.
Abbott’s SARS-CoV-2 tests are for use under an Emergency Use Authorization (EUA) Only:
- Prescription Use only.
- These tests have not been FDA cleared or approved.
- These tests have been authorized by FDA under EUA for use by authorized laboratories.
- These tests have been authorized only for the detection of IgG and the presence of IgM antibodies against SARS-CoV-2, not for any other viruses or pathogens.
- These tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
REFERENCES
- Havers FP, Reed C, Lim T, et al. Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.